AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2025
Oct 14, 2025
35599_dirs_2025-10-14_afb4f03a-39bf-4616-b219-a727c6e78c9e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2025-10-10
Reporting Person: RALLIS CHRIS A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-10 | Common Shares | M | 4062 | $1.23 | Acquired | 58854 | Direct |
| 2025-10-10 | Common Shares | S | 1775 | $9.24 | Disposed | 57079 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-10 | Common Shares | $1.23 | M | 4062 | Disposed | 2025-11-10 | Options (4062) | Direct |
Footnotes
F1: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025.
F2: Shares sold to satisfy tax obligation on option exercise.
F3: Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20